Ivic Ivan, Solymar Margit, Fulop Balazs D, Hashimoto Hitoshi, Toth Gabor, Tamas Andrea, Juhasz Tamas, Koller Akos, Reglodi Dora
Department of Anatomy, MTA-PTE PACAP Research Group, Medical School, University of Pecs, Pecs, Hungary.
J Vasc Res. 2017;54(6):359-366. doi: 10.1159/000481781. Epub 2017 Nov 9.
Pituitary adenylate cyclase-activating peptide (PACAP; 1-38 and 1-27) and vasoactive intestinal peptide (VIP) are related neuropeptides of the secretin/glucagon family. Overlapping signaling through G-protein-coupled receptors mediates their vasomotor activity. We previously showed that PACAP deficiency (PACAP-KO) shifts the mechanisms of vascular response and maintains arterial relaxation through the VIP backup mechanism and (mainly) its VPAC1R, but their age-dependent modulation is still unknown. We hypothesized that backup mechanisms exist, which maintain the vasomotor activity of these peptides also in older age. Thus, we investigated the effects of exogenous VIP and PACAP peptides in isolated carotid arteries of 2- and 15-month-old wild-type (WT) and PACAP-KO mice. All peptides induced relaxation in the arteries of young WT mice, whereas in young PACAP-KO mice PACAP1-27 and VIP, but not PACAP1-38, induced relaxation. Unlike VIP, PACAP-induced vasomotor responses were reduced in aging WT mice. However, in the arteries of aging PACAP-KO mice, PACAP1-27- and VIP-induced responses were reduced, but PACAP1-38 showed a greater vasomotor response compared to that of young PACAP-KO animals. There were no significant differences between the vasomotor responses of aging WT and PACAP-KO mice. Our data suggest that, in the absence of PACAP both in young and old ages, the vascular response is mediated through backup mechanisms, most likely VIP, maintaining proper vascular relaxation in aging-induced PACAP insufficiency.
垂体腺苷酸环化酶激活肽(PACAP;1 - 38和1 - 27)和血管活性肠肽(VIP)是促胰液素/胰高血糖素家族中的相关神经肽。通过G蛋白偶联受体的重叠信号传导介导它们的血管舒缩活性。我们之前表明,PACAP缺乏(PACAP基因敲除)会改变血管反应机制,并通过VIP备用机制(主要是其VPAC1R)维持动脉舒张,但它们的年龄依赖性调节仍不清楚。我们假设存在备用机制,在老年时也能维持这些肽的血管舒缩活性。因此,我们研究了外源性VIP和PACAP肽对2月龄和15月龄野生型(WT)及PACAP基因敲除小鼠离体颈动脉的影响。所有肽都能诱导年轻WT小鼠动脉舒张,而在年轻的PACAP基因敲除小鼠中,PACAP1 - 27和VIP能诱导舒张,但PACAP1 - 38不能。与VIP不同,PACAP诱导的血管舒缩反应在衰老的WT小鼠中降低。然而,在衰老的PACAP基因敲除小鼠动脉中,PACAP1 - 27和VIP诱导的反应降低,但与年轻的PACAP基因敲除动物相比,PACAP1 - 38显示出更大的血管舒缩反应。衰老的WT和PACAP基因敲除小鼠的血管舒缩反应之间没有显著差异。我们的数据表明,无论在年轻还是老年,在缺乏PACAP的情况下,血管反应是通过备用机制介导的,最有可能是VIP,在衰老诱导的PACAP不足时维持适当的血管舒张。